May Lee M, Di Lernia V, Peccerillo F, Bardazzi F, Tabanelli M, Ricci M, et al. Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy. Dermatol Reports [Internet]. 2025 Jul. 1 [cited 2026 May 31];18(1). Available from: https://journals.pagepress.net/dr/article/view/10315